Nanomedicine News

RSS

Researchers Develop Thermodynamically Stable RNA Nanoparticle

The University of Cincinnati (UC) researchers have discovered a RNA nano-scaffold that is thermodynamically stable in the body. This discovery further leads to the advancement of therapeutic RNA nanotechnology.

15 Sep 2011

Aura Biosciences’ NanoSmart Platform Offers Precisely Targeted Treatment for Cancers

The data from numerous pre-clinical research programs completed by Aura Biosciences shows that the company’s NanoSmart platform is able to detect distant metastases and cancers early and offers accurately focused treatment for those cancers.

13 Sep 2011

University of New Mexico Inaugurates Nanomedicine and Nanotechnology Laboratory

A new nanomedicine and nanotechnology laboratory has been opened on the third floor of the Centennial Engineering Center of the University of New Mexico.

From Sandia National Laboratories 12 Sep 2011

3M Drug Delivery Systems Introduces 3M Microchannel Skin System

3M Drug Delivery Systems has launched its new tool called 3M Microchannel Skin System, which allows dermatologists to perform pretreatment on patients’ skin before dermatological procedures and applications.

From 3M Co. 12 Sep 2011

Survey Study on Nanotechnology and Dermatology Education in the US

The Nanodermatology Society has released a pilot study titled ‘Nanotechnology and dermatology education in the United States: Data from a pilot survey’ that assesses attitudes, perceptions and knowledge of dermatologists in the US concerning nanotechnology.

5 Sep 2011

Researcher Receives Grant to Develop Tissue-Specific Nanotherapeutics for Breast Cancer

Xiaoting Zhang, who serves as Assistant Professor at University of Cincinnati’s cancer and cell biology department, has received a U.S. Department of Defense Breast Cancer Idea Award worth $587,000 to devise tissue-specific nanotherapeutics for human breast cancer treatment.

3 Sep 2011

Tekmira to Develop RNAi Therapeutic Drugs Using MV-RNA molecules and its Lipid Nanoparticle Technology

Tekmira Pharmaceuticals has inked an exclusive, global license and partnership deal with Halo-Bio RNAi Therapeutics for its innovative and proprietary RNAi technology known as multivalent RNA (MV-RNA) to develop MV-RNA molecules and therapeutic products by coupling Tekmira's lipid nanoparticle (LNP) technology and MV-RNA molecules.

29 Aug 2011

Study Reveals that Nanoparticles Interrupt Transport Mechanism in Cells

Researchers at the Norwegian Radium Hospital’s Centre of Cancer Biomedicine have demonstrated that the introduction and storing of nanoparticles within cells will have a detrimental effect on the transportation of critical substances into and out of the cells, resulting in unwanted changes in the physiology of the cells and their functioning.

26 Aug 2011

Activation of Cellular Pathway by Nickel Nanoparticles May Trigger Lung Cancer

Brown University researchers have discovered that nickel nanoparticles trigger a cellular pathway called HIF-1 alpha that leads to cancer in human lung cells.

26 Aug 2011

Activus Pharma to Receive NEDO Grant to Develop Nanotechology-Based Ophthalmic Solutions

As part of its FY2011 Innovation Promotion Programme, the Ministry of Economy, Trade and Industry’s Incorporated Administrative Agency, New Energy and Industrial Technology Development Organization (NEDO) will award a grant to Sosei Group’s subsidiary Activus Pharma for the development of advanced ophthalmic solutions.

25 Aug 2011